79 related articles for article (PubMed ID: 18161177)
1. Recent developments in bisphosphonates for patients with metastatic breast cancer.
Gainford MC; Dranitsaris G; Clemons M
BMJ; 2005 Apr; 330(7494):769-73. PubMed ID: 15802719
[No Abstract] [Full Text] [Related]
2. Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".
Combs SE; Debus J; Feick G; Hadaschik B; Hohenfellner M; Schüle R; Zacharias JP; Schwardt M
Radiat Oncol; 2014 Nov; 9():224. PubMed ID: 25381175
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.
Bankhead C
J Natl Cancer Inst; 2003 Sep; 95(17):1273-4. PubMed ID: 12953081
[No Abstract] [Full Text] [Related]
4. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
5. Bone complications: an increasing risk in patients with prostate cancer.
J Support Oncol; 2007 Feb; 5(2):88-9. PubMed ID: 17348369
[No Abstract] [Full Text] [Related]
6. [Therapeutic guidelines in prostate cancer and role for bisphosphonates in bone metastasis].
Miki T; Okihara K
Nihon Rinsho; 2007 Nov; 65 Suppl 9():632-5. PubMed ID: 18161177
[No Abstract] [Full Text] [Related]
7. [Expert consensus for the diagnosis and treatment of bone metastasis from prostate cancer].
Expert Group on the Diagnosis and Treatment of Bone Metastasis from Prostate Cancer
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):396-8. PubMed ID: 20723442
[No Abstract] [Full Text] [Related]
8. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
9. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
Smith MR
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
[TBL] [Abstract][Full Text] [Related]
10. The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.
Saad F; Higano CS; Sartor O; Colombel M; Murray R; Mason MD; Tubaro A; Schulman C
Clin Genitourin Cancer; 2006 Mar; 4(4):257-62. PubMed ID: 16729908
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
